Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracellular Signaling Peptides and Proteins | 12 | 2022 | 285 | 2.700 |
Why?
|
| Neoplastic Stem Cells | 8 | 2020 | 141 | 1.650 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2020 | 133 | 1.530 |
Why?
|
| Liver Neoplasms | 6 | 2020 | 167 | 1.290 |
Why?
|
| Hepacivirus | 4 | 2013 | 49 | 1.000 |
Why?
|
| Microtubules | 2 | 2016 | 90 | 0.870 |
Why?
|
| beta Catenin | 2 | 2022 | 66 | 0.830 |
Why?
|
| Hepatocytes | 3 | 2020 | 88 | 0.820 |
Why?
|
| Virus Replication | 3 | 2013 | 66 | 0.650 |
Why?
|
| Antiviral Agents | 2 | 2016 | 114 | 0.560 |
Why?
|
| Cell Line, Tumor | 10 | 2020 | 1350 | 0.540 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 32 | 0.480 |
Why?
|
| Stilbenes | 1 | 2016 | 91 | 0.470 |
Why?
|
| Inflammation | 2 | 2021 | 667 | 0.460 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 22 | 0.420 |
Why?
|
| RNA, Viral | 2 | 2011 | 68 | 0.390 |
Why?
|
| Mice | 14 | 2020 | 4802 | 0.390 |
Why?
|
| Indoles | 1 | 2013 | 110 | 0.380 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 465 | 0.330 |
Why?
|
| Animals | 17 | 2021 | 10684 | 0.330 |
Why?
|
| Carcinogenesis | 2 | 2021 | 81 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 120 | 0.320 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2009 | 1 | 0.320 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2009 | 6 | 0.320 |
Why?
|
| Genes, src | 1 | 2009 | 4 | 0.320 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 20 | 0.320 |
Why?
|
| Cell Proliferation | 7 | 2016 | 824 | 0.300 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2017 | 120 | 0.300 |
Why?
|
| Liver Cirrhosis | 3 | 2020 | 78 | 0.300 |
Why?
|
| Antineoplastic Agents | 4 | 2016 | 686 | 0.290 |
Why?
|
| Humans | 18 | 2022 | 28851 | 0.290 |
Why?
|
| Epithelial Cells | 6 | 2016 | 265 | 0.290 |
Why?
|
| Replicon | 2 | 2011 | 7 | 0.290 |
Why?
|
| Cell Survival | 5 | 2017 | 419 | 0.280 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 415 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 1653 | 0.250 |
Why?
|
| Liver | 3 | 2016 | 471 | 0.250 |
Why?
|
| Intestinal Mucosa | 4 | 2015 | 198 | 0.250 |
Why?
|
| Radiation Injuries | 2 | 2016 | 52 | 0.230 |
Why?
|
| Mice, Nude | 3 | 2015 | 332 | 0.220 |
Why?
|
| Benzodiazepinones | 2 | 2014 | 13 | 0.220 |
Why?
|
| Gene Deletion | 2 | 2015 | 120 | 0.220 |
Why?
|
| Stem Cells | 5 | 2016 | 123 | 0.210 |
Why?
|
| MicroRNAs | 4 | 2015 | 302 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 3 | 2015 | 548 | 0.210 |
Why?
|
| Flow Cytometry | 2 | 2016 | 292 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2015 | 146 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2016 | 275 | 0.190 |
Why?
|
| Whole-Body Irradiation | 4 | 2016 | 40 | 0.190 |
Why?
|
| Calgranulin B | 1 | 2022 | 17 | 0.190 |
Why?
|
| Quinolones | 1 | 2022 | 22 | 0.190 |
Why?
|
| Spheroids, Cellular | 2 | 2020 | 53 | 0.190 |
Why?
|
| Chemokines | 1 | 2022 | 74 | 0.190 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 82 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2017 | 1469 | 0.180 |
Why?
|
| Bystander Effect | 1 | 2021 | 16 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 2015 | 668 | 0.170 |
Why?
|
| SOX9 Transcription Factor | 1 | 2020 | 12 | 0.170 |
Why?
|
| alpha-Fetoproteins | 1 | 2020 | 18 | 0.170 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 31 | 0.160 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 42 | 0.160 |
Why?
|
| Heterografts | 1 | 2020 | 66 | 0.160 |
Why?
|
| Cytokines | 1 | 2022 | 451 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 142 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 138 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 134 | 0.150 |
Why?
|
| Intestines | 2 | 2016 | 118 | 0.140 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 8 | 0.130 |
Why?
|
| Receptors, Notch | 2 | 2014 | 44 | 0.130 |
Why?
|
| Cell-Free System | 2 | 2009 | 21 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 16 | 0.130 |
Why?
|
| Hepatitis | 1 | 2016 | 7 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 328 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 634 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 198 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 2 | 2015 | 66 | 0.120 |
Why?
|
| RNAi Therapeutics | 1 | 2015 | 13 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1507 | 0.120 |
Why?
|
| Pectins | 1 | 2015 | 7 | 0.120 |
Why?
|
| Dextran Sulfate | 1 | 2015 | 9 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2016 | 163 | 0.120 |
Why?
|
| Mucositis | 1 | 2015 | 7 | 0.120 |
Why?
|
| Radiation-Protective Agents | 1 | 2015 | 22 | 0.120 |
Why?
|
| DNA Damage | 1 | 2016 | 152 | 0.120 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2015 | 31 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 122 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2015 | 66 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 133 | 0.120 |
Why?
|
| Colitis | 1 | 2015 | 54 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 26 | 0.110 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 13 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 15 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2015 | 124 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2016 | 515 | 0.110 |
Why?
|
| Colon | 1 | 2015 | 123 | 0.110 |
Why?
|
| Liver Regeneration | 1 | 2014 | 6 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 32 | 0.100 |
Why?
|
| Transcriptome | 1 | 2015 | 231 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 202 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2014 | 128 | 0.100 |
Why?
|
| Wound Healing | 1 | 2014 | 126 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2014 | 89 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 165 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2015 | 427 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 148 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2014 | 152 | 0.090 |
Why?
|
| Keratin-19 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 60 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2011 | 42 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 194 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 278 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2016 | 288 | 0.080 |
Why?
|
| RNA Caps | 1 | 2009 | 2 | 0.080 |
Why?
|
| Tumor Burden | 3 | 2015 | 110 | 0.080 |
Why?
|
| 5' Untranslated Regions | 1 | 2009 | 9 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 513 | 0.080 |
Why?
|
| HeLa Cells | 1 | 2009 | 212 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 164 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2009 | 96 | 0.070 |
Why?
|
| Gene Expression | 3 | 2015 | 417 | 0.070 |
Why?
|
| Apoptosis | 3 | 2016 | 780 | 0.070 |
Why?
|
| Cell Line | 2 | 2014 | 700 | 0.060 |
Why?
|
| Female | 5 | 2017 | 15624 | 0.060 |
Why?
|
| Receptor, Notch1 | 2 | 2017 | 27 | 0.060 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2005 | 2 | 0.060 |
Why?
|
| RNA Interference | 2 | 2015 | 137 | 0.060 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 154 | 0.050 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 87 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 300 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2002 | 34 | 0.050 |
Why?
|
| Biomarkers | 2 | 2016 | 776 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 472 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2021 | 15 | 0.040 |
Why?
|
| Genes, APC | 1 | 2017 | 14 | 0.030 |
Why?
|
| Enterocytes | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 126 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2016 | 42 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 32 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 68 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 39 | 0.030 |
Why?
|
| Male | 3 | 2017 | 13921 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 49 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 75 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2015 | 35 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 585 | 0.030 |
Why?
|
| CA-19-9 Antigen | 1 | 2015 | 7 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 319 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 62 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 247 | 0.030 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2014 | 6 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 60 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 50 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 38 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 16 | 0.030 |
Why?
|
| ras Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 50 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 141 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2014 | 53 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2014 | 88 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2014 | 27 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 314 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 44 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2014 | 52 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 62 | 0.030 |
Why?
|
| Adenoma | 1 | 2014 | 61 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 45 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 20 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2014 | 118 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 480 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 874 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 140 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 685 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 65 | 0.030 |
Why?
|
| Binding Sites | 1 | 2014 | 355 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 156 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 867 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 739 | 0.020 |
Why?
|
| Polymers | 1 | 2014 | 117 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1022 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 103 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2015 | 272 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 376 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 667 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 523 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1613 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 490 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 2635 | 0.020 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2005 | 12 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 34 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 111 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 5598 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 588 | 0.010 |
Why?
|
| Autoantigens | 1 | 2005 | 212 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 7414 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1056 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 8024 | 0.010 |
Why?
|